The overexpression of Fra1 disorders the inflammatory cytokine secretion by mTEC of myasthenia gravis thymus
Authors:
- 28 May 2018
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 88 (1) , e12676
Abstract
The thymus of a myasthenia gravis (MG) patient is often accompanied by and effected with follicular hyperplasia. Inflammatory cytokines in thymus induce the formation of germinal centres (GC). MG thymic inflammatory cytokines are predominantly secreted by stromal cells. Our previous studies revealed that the expression level of the Fra1 protein, which is a Fos member of the activator protein 1 transcription factors (AP‐1), was higher in the MG thymus compared with that of the normal thymus. Based on that, we demonstrated that Fra1 was mainly expressed in medulla thymic epithelial cells (mTECs) and that the rate of Fra1 positive mTECs in the MG thymus was higher than normal. In vitro, we found that the expression of CCL‐5, CCL‐19 and CCL‐21 could be regulated by Fra1 in mTEC and that IL‐1β, IL‐6, IL‐8 and ICAM1 were downregulated in the Fra1 overexpression group and upregulated in the Fra1 knock‐down group. Meanwhile, we detected that the expression levels of suppressor of cytokine signalling 3 (SOCS3) were significantly upregulated along with the overexpression of Fra1. Hence, we considered that the overexpression of Fra1 disrupted inflammatory cytokine secretion by mTEC in the MG thymus and that STAT3 and SOCS3 were strongly involved in this process.Keywords
Funding Information
- National Natural Science Foundation of China (81471545)
This publication has 38 references indexed in Scilit:
- The thymus in myasthenia gravis: Site of “innate autoimmunity”?Muscle & Nerve, 2011
- The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progressionOncogene, 2009
- Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravisEuropean Journal of Neurology, 2009
- CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myastheniaAnnals of Neurology, 2009
- Monitoring treatment with cyclosporine microemulsion in myasthenia gravisEuropean Journal of Neurology, 2008
- Heterodimerization with Jun Family Members Regulates c-Fos Nucleocytoplasmic TrafficJournal of Biological Chemistry, 2007
- Inhibition of AMP-activated protein kinase suppresses IL-2 expression through down-regulation of NF-AT and AP-1 activation in Jurkat T cellsBiochemical and Biophysical Research Communications, 2006
- Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteinsNature, 2005
- DEP-inducedfra-1expression correlates with a distinct activation of AP-1-dependent gene transcription in the lungAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Activation of the Wnt Pathway Interferes with Serum Response Element-driven Transcription of Immediate Early GenesJournal of Biological Chemistry, 2002